The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease (NCT05811364)

🧪 Interventions in This Study

• Stenting of the Common and/or External Iliac Arteries with the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (DEVICE)
• Stenting of the Common and/or External Iliac Arteries with Bare Metal Stent (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (43 Sites)

Showing the first 25 of 43 sites.

• Central Arkansas Veterans Healthcare System — Little Rock, Arkansas
• VA Long Beach Healthcare System — Long Beach, California
• Denver Health and Hospital Authority — Denver, Colorado
• North Suburban Medical Center — Denver, Colorado
• University of Florida - Gainesville — Gainesville, Florida
• Radiology and Imaging Specialists of Lakeland — Lakeland, Florida
• University of South Florida — Tampa, Florida
• Atlanta VA Medical Center — Decatur, Georgia
• Louisiana State University Health Sciences Center — New Orleans, Louisiana
• Beth Israel Deaconess Medical Center, Inc. — Boston, Massachusetts
• Corewell Health System — Grand Rapids, Michigan
• The Curators of the University of Missouri — Columbia, Missouri
• Research Foundation SUNY Buffalo — Amherst, New York
• Trinity Medical Center — Buffalo, New York
• VA Western New York Healthcare System — Buffalo, New York
• New York University School of Medicine — New York, New York
• Mt. Sinai Medical Center — New York, New York
• Atrium Health — Charlotte, North Carolina
• University Hospitals - Cleveland Medical Center — Ashland, Ohio
• Cleveland Clinic Foundation — Cleveland, Ohio
• Portland Health Care System VA — Portland, Oregon
• Providence Heart & Vascular Institute — Wilsonville, Oregon
• University of Pennsylvania — Philadelphia, Pennsylvania
• Wellmont Holston Valley Medical Center — Kingsport, Tennessee
• The University of Texas Southwestern Medical Center — Dallas, Texas

📞 Contact the Study Coordinator

Phone: (337) 387-4954

Email: aambroc@wlgore.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Aortoiliac Occlusive Disease

• Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease — Fresno, California

Explore by condition: All Aortoiliac Occlusive Disease clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.